Log In
Print
BCIQ
Print
Print this Print this
 

morphine/oxycodone (MoxDuo IR) (Q8003 IR)

  Manage Alerts
Collapse Summary General Information
Company QRxPharma Ltd.
DescriptionImmediate-release combination of oxycodone and morphine
Molecular Target Mu opioid receptor (OPRM1) (MOR)
Mechanism of ActionMu opioid receptor agonist
Latest Stage of DevelopmentRegistration
IndicationPain
Partner

Actavis Inc.; Paladin Labs Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today